Baseline levels of circulating galectin-1 associated with radiographic hand but not radiographic knee osteoarthritis at a two-year follow-up
- PMID: 38469554
- PMCID: PMC10926207
- DOI: 10.1016/j.ocarto.2024.100455
Baseline levels of circulating galectin-1 associated with radiographic hand but not radiographic knee osteoarthritis at a two-year follow-up
Abstract
Objective: We tested the potential of circulating galectin-1, interleukin (IL)-1 beta, IL-6, and tumour necrosis factor alpha (TNF alpha) levels at baseline in individuals with knee pain as biomarkers for development of radiographic knee and/or hand osteoarthritis (OA).
Design: This study comprised 212 individuals with knee pain from the Halland osteoarthritis cohort (HALLOA). Clinical characteristics and serum/plasma levels of galectin-1, IL-1 beta, IL-6, and TNF alpha were measured at baseline, and knee and hand radiographs were obtained at a two-year follow-up. The predictive value of circulating inflammatory markers and clinical variables at baseline was assessed using multinominal logistic regression for those who developed radiographic OA in knees only (n = 25), in hands only (n = 40), and in both knees and hands (n = 43); the group who did not develop OA (n = 104) was used as reference. Correlations were assessed using Spearman's correlation coefficients.
Results: As expected, age was identified as a risk factor for having radiographic knee and/or hand OA at the two-year follow-up. Baseline circulating galectin-1 levels did not associate with developing radiographic knee OA but associated with developing radiographic hand OA (odds ratio (OR) for a 20% increased risk: 1.14, 95% confidence interval (CI) 1.01-1.29) and both radiographic knee and hand OA (OR for a 20% increased risk: 1.18, 95% CI 1.05-1.30). However, baseline IL-1 beta, IL-6, and TNF alpha did not associate with developing radiographic knee and/or hand OA.
Conclusion: Non-age adjusted circulating galectin-1 is superior to IL-6, IL-1 beta, and TNF alpha in predicting radiographic hand but not knee OA.
Keywords: Galectin-1; Hand; Knee; Osteoarthritis.
© 2024 The Author(s).
Conflict of interest statement
There are no conflicts of interest.
References
-
- Sellam J., Berenbaum F. Is osteoarthritis a metabolic disease? Joint, bone, spine. revue du rhumatisme. 2013;80(6):568–573. - PubMed
-
- de Oliveira P.S.S., Cardoso P.R.G., de Paula Silva S.K., Duarte A., da Rosa M.M., de Melo Rego M.J.B., et al. High serum levels of galectins 1 and 4 in osteoarthritis patients. Clin. Biochem. 2023;116:11–15. - PubMed
-
- Salamanna F., Veronesi F., Frizziero A., Fini M. Role and translational implication of galectins in arthritis pathophysiology and treatment: a systematic literature review. J. Cell. Physiol. 2019;234(2):1588–1605. - PubMed
-
- Sundblad V., Morosi L.G., Geffner J.R., Rabinovich G.A. Galectin-1: a jack-of-all-trades in the resolution of acute and chronic inflammation. J. Immunol. 2017;199(11):3721–3730. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
